Home
MOA of PCSK9i
PCSK9i Therapies
PCSK9i CVOTs
ACC/AHA Guidelines
IfPA Report Card
NLA Survey Results
PCSK9i Pricing Update
Improving Patient Access
Summary

PCSK9i Pricing Update

PCSK9i Pricing Updates

https://www.prnewswire.com/news-releases/sanofi-and-regeneron-offer-praluent-alirocumab-at-a-new-reduced-us-list-price-300792876.htmlhttps://www.amgen.com/media/news-releases/2018/10/amgen-makes-repatha-evolocumab-available-in-the-us-at-a-60-percent-reduced-list-price/